CELL BIOTECH CO ., LTD Logo

CELL BIOTECH CO ., LTD

A global biotech firm offering probiotic raw materials, OEM/ODM services, and consumer brands.

049960 | KO

Overview

Corporate Details

ISIN(s):
KR7049960008
LEI:
Country:
South Korea
Address:
경기 김포시 월곶면 개곡리 134, 김포시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cell Biotech Co., Ltd. is a biotechnology company specializing in the research, development, manufacturing, and marketing of innovative probiotic solutions. Leveraging over 30 years of experience and proprietary fermentation and coating technologies, the company produces high-quality lactic acid bacteria (LAB) and GRAS-safe strains. Its core business includes producing probiotic raw materials, marketed as LAB2PRO; offering comprehensive OEM/ODM services for finished products tailored to global clients; and managing its own consumer brand, DUOLAC, which is exported to approximately 40 countries.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.1 MB
2025-08-07 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.2 KB
2025-07-25 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.5 MB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 893.4 KB
2025-05-09 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.2 KB
2025-04-30 00:00
Regulatory News Service
소속부변경
Korean 3.6 KB
2025-04-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-04-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-04-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.0 KB
2025-03-27 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 29.3 KB
2025-03-19 00:00
Audit Report / Information
감사보고서제출
Korean 25.7 KB
2025-03-19 00:00
Audit Report / Information
[첨부추가]사업보고서 (2024.12)
Korean 438.4 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 112.4 KB
2025-03-13 00:00
Proxy Solicitation & Information Statement
[기재정정]의결권대리행사권유참고서류
Korean 107.7 KB
2025-03-12 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 108.1 KB

Automate Your Workflow. Get a real-time feed of all CELL BIOTECH CO ., LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CELL BIOTECH CO ., LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CELL BIOTECH CO ., LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

JETEMA Co.,Ltd. Logo
Research-driven developer of aesthetic toxins, dermal fillers, and threads.
South Korea
216080
Develops and manufactures high-tech drugs for cancer, diabetes, and a range of diseases.
South Korea
007370
JOHNSON & JOHNSON Logo
Develops innovative medicines and medical technologies for complex diseases and personalized care.
United States of America
JNJ
Journey Medical Corp Logo
A pharmaceutical firm commercializing prescription drugs and generics for dermatology.
United States of America
DERM
JUPITER NEUROSCIENCES, INC. Logo
Pharma firm developing resveratrol treatments for neuroinflammation and rare diseases.
United States of America
JUNS
JW LIFESCIENCE CORPORATION Logo
A leading developer and manufacturer of infusion solutions, from basic IV fluids to complex nutrients.
South Korea
234080
JW SHINYAK CORPORATION Logo
Develops specialty medicines for the dermatology, urology, and otolaryngology clinical markets.
South Korea
067290
Jyong Biotech Ltd. Logo
Develops plant-derived drugs for urinary system diseases, with a lead candidate in Phase III trials.
United States of America
MENS
Kadimastem Ltd. Logo
Develops off-the-shelf stem cell therapies for diabetes & neurodegenerative diseases.
Israel
KDST
kainos loboratories,inc Logo
Develops, manufactures, and sells innovative clinical diagnostic reagents for the healthcare industry.
Japan
4556

Talk to a Data Expert

Have a question? We'll get back to you promptly.